US Patent Issued to Therini Bio on April 8 for "Antibodies which bind human fibrin or fibrinogen GammaC domain and methods of use" (California, New Hampshire Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,894, issued on April 8, was assigned to Therini Bio Inc. (South San Francisco, Calif.).

"Antibodies which bind human fibrin or fibrinogen GammaC domain and methods of use" was invented by Jeffrey Stavenhagen (San Mateo, Calif.), Olga Gasiorowska (Sacramento, Calif.), Mathias Rickert (Hayward, Calif.), Paul Fredrick Widboom (Lebanon, N.H.) and Joseph Robert Warfield (Lebanon, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are novel and improved antibodies that bind human fibrin or fibrinogen GammaC domain and methods of use thereof. In certain aspects, described herein are methods of inhibiting microglial activation. In certain ...